Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Moderna Inc Corporate Analyst Meeting Transcript

Apr 14, 2020 / 12:00PM GMT
Release Date Price: $34.66 (+5.35%)
Operator

Good morning and welcome to Moderna's Virtual Vaccine Day. (Operator Instructions) Please be advised that this call is being recorded. At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.

Lavina Talukdar
Moderna, Inc. - Head of IR

Thank you, operator, and good morning, everyone. I hope you are all healthy and safe. Thank you for joining Moderna's First Vaccine Day webcast.

During the presentations today, you will hear from members of Moderna's executive team and from key opinion leaders in the industry. You can access the press release and the slides accompanying each of the speakers' presentations by going to the Investors section of our website. Before we begin, I'd like to remind everyone that this presentation will include forward-looking statements. Please see Slide 2 of the presentation and our SEC filings for important risk factors that could cause our actual performance and results to differ materially from those expressed or implied in these forward-looking statements. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot